These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24724423)

  • 1. [Effects of four bisphosphonates on macrophage phagocytosis: quantitative measurement by flow cytometry using high-fluorescence particles and human monocytic cell line THP-1].
    Imoto S; Saigo K; Bohgaki M; Matsumoto E; Goto M
    Rinsho Byori; 2014 Jan; 62(1):23-30. PubMed ID: 24724423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
    Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
    Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of macrophage viability, differentiation, and function by bisphosphonates.
    Patntirapong S; Poolgesorn M
    Oral Dis; 2018 Oct; 24(7):1294-1302. PubMed ID: 29869362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Hoefert S; Sade Hoefert C; Munz A; Northoff H; Yuan A; Reichenmiller K; Reinert S; Grimm M
    Clin Oral Investig; 2016 Jun; 20(5):1043-54. PubMed ID: 26349768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Hoefert S; Hoefert CS; Albert M; Munz A; Grimm M; Northoff H; Reinert S; Alexander D
    Clin Oral Investig; 2015 Jul; 19(6):1307-18. PubMed ID: 25411080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Hoefert S; Sade Hoefert C; Munz A; Schmitz I; Grimm M; Yuan A; Northoff H; Reinert S; Alexander D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):222-32. PubMed ID: 26725718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
    Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
    Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphonocarboxylates Can Protect Mice against the Inflammatory and Necrotic Side Effects of Nitrogen-Containing Bisphosphonates by Inhibiting Their Entry into Cells via Phosphate Transporters.
    Kiyama T; Tsuchiya M; Okada S; Oizumi T; Yamaguchi K; Sasaki K; Sugawara S; Endo Y
    Biol Pharm Bull; 2016; 39(5):712-20. PubMed ID: 27150143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development.
    Soares AP; do Espírito Santo RF; Line SR; Pinto Md; Santos Pde M; Toralles MB; do Espírito Santo AR
    Environ Toxicol Pharmacol; 2016 Mar; 42():212-7. PubMed ID: 26895384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
    Hagelauer N; Pabst AM; Ziebart T; Ulbrich H; Walter C
    Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
    Minegaki T; Fukushima S; Morioka C; Takanashi H; Uno J; Tsuji S; Yamamoto S; Watanabe A; Tsujimoto M; Nishiguchi K
    Dis Esophagus; 2016 Aug; 29(6):656-62. PubMed ID: 25894100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate attenuates eosinophilic airway inflammation associated with suppression of Th2 cytokines, Th17 cytokines, and eotaxin-2.
    Sasaki O; Imamura M; Yamazumi Y; Harada H; Matsumoto T; Okunishi K; Nakagome K; Tanaka R; Akiyama T; Yamamoto K; Dohi M
    J Immunol; 2013 Sep; 191(6):2879-89. PubMed ID: 23935198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs.
    Shima K; Tsuchiya M; Oizumi T; Takano-Yamamoto T; Sugawara S; Endo Y
    Biol Pharm Bull; 2017; 40(1):25-33. PubMed ID: 28049945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
    Vorotnjak M; Boos J; Lanvers-Kaminsky C
    Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
    Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
    J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology of the aging bone and mechanisms of action of bisphosphonates.
    Dominguez LJ; Di Bella G; Belvedere M; Barbagallo M
    Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
    Okada S; Kiyama T; Sato E; Tanaka Y; Oizumi T; Kuroishi T; Takahashi T; Sasaki K; Sugawara S; Endo Y
    Tohoku J Exp Med; 2013 Oct; 231(2):145-58. PubMed ID: 24140868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
    Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
    Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.